Sleep — Age-Related Changes in Sleep-Dependent Emotional Memory
Citation(s)
Baran B, Pace-Schott EF, Ericson C, Spencer RM Processing of emotional reactivity and emotional memory over sleep. J Neurosci. 2012 Jan 18;32(3):1035-42. doi: 10.1523/JNEUROSCI.2532-11.2012.
Charles ST, Mather M, Carstensen LL Aging and emotional memory: the forgettable nature of negative images for older adults. J Exp Psychol Gen. 2003 Jun;132(2):310-24.
Charles ST, Reynolds CA, Gatz M Age-related differences and change in positive and negative affect over 23 years. J Pers Soc Psychol. 2001 Jan;80(1):136-51.
Dalgleish T, Werner-Seidler A Disruptions in autobiographical memory processing in depression and the emergence of memory therapeutics. Trends Cogn Sci. 2014 Nov;18(11):596-604. doi: 10.1016/j.tics.2014.06.010. Epub 2014 Jul 21. Review.
Jones BJ, Schultz KS, Adams S, Baran B, Spencer RMC Emotional bias of sleep-dependent processing shifts from negative to positive with aging. Neurobiol Aging. 2016 Sep;45:178-189. doi: 10.1016/j.neurobiolaging.2016.05.019. Epub 2016 May 27.
Mather M, Carstensen LL Aging and motivated cognition: the positivity effect in attention and memory. Trends Cogn Sci. 2005 Oct;9(10):496-502. Review.
Mroczek DK, Kolarz CM The effect of age on positive and negative affect: a developmental perspective on happiness. J Pers Soc Psychol. 1998 Nov;75(5):1333-49.
Speer ME, Bhanji JP, Delgado MR Savoring the past: positive memories evoke value representations in the striatum. Neuron. 2014 Nov 19;84(4):847-56. doi: 10.1016/j.neuron.2014.09.028. Epub 2014 Oct 30.
AGE-RELATED CHANGES IN SLEEP-DEPENDENT EMOTIONAL MEMORY
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
